drugset / Trial / NCT04131595
Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects
Non-randomizedParallel-groupOpen-labelPrevention
Summary
To assess safety and tolerability as well as immune responses to the MVA-BN-WEV vaccine in the 3 treatment groups receiving different doses.
Timeline
- Start
- 2019-10-07
- Primary completion
- 2020-07-22
- Completion
- 2020-07-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MVA-BN-WEV | Vaccine | 1e+07 unknown | — |
| Subject | MVA-BN-WEV | Vaccine | 1e+08 unknown | — |
| Subject | MVA-BN-WEV | Vaccine | 2e+08 unknown | — |